IFITM3 and early-onset autosomal dominant Alzheimer disease: In some study about neurodegeneration, such as Alzheimer’s disease, investigators have found that IFITM3 can act as γ-secretase modulatory protein and increase the deposition of amyloid-beta in brain via inflammatory mechanisms (Hur et al., 2020).